EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Haibao Peng, Feibai Yao, Jiaxu Zhao, Wei Zhang, Lingchao Chen, Xin Wang, Peng Yang iD, Jing Tang, Yudan Chi

Exploration · 2023-04 · 3 (2)

DOI: 10.1002/exp.20220115 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Exploration, online erschienen am 05.04.2023. Verfasst von Haibao Peng und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers…. Die Arbeit wurde bisher 137-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Natural Science Foundation of Shanghai, American Association for Cancer Research, Fundamental Research Funds for the Central Universities.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Functional subcellular organelle mitochondria are emerging as a crucial player and driver of cancer. For maintaining the sites of cellular respiration, mitochondria experience production, and accumulation of reactive oxygen species (ROS) underlying oxidative damage in electron transport chain carriers. Precision medicine targeting mitochondria can change nutrient availability and redox homeostasis in cancer cells, which might represent a promising strategy for suppressing tumor growth. Herein, this review highlights how the modification capable of manipulating nanomaterials for ROS generation strategies can influence or compensate the state of mitochondrial redox homeostasis. We propose foresight to guide research and innovation with an overview of seminal work and discuss future challenges and our perspective on the commercialization of novel mitochondria‐targeting agents.

Schlagwörter

Stichwörter der Autor:innen

cancer therapymitochondria‐targetingnanomaterialsreactive oxygen species

Autor:innen und Institutionen

  • Department of Neurosurgery, Huashan Hospital, Institute for Translational Brain Research, State Key Laboratory of Medical Neurobiology, MOE Frontiers Center for Brain Science Fudan University Shanghai China.
  • Engineering Research Center of Molecular- and Neuro-imaging of Ministry of Education, School of Life Science and Technology Xidian University Xi'an Shaanxi China.
  • Department of Materials Science and Engineering Stanford University Stanford California USA.

ORCID-Profile: Peng Yang

Förderung

  • Natural Science Foundation of Shanghai
  • American Association for Cancer Research
  • Fundamental Research Funds for the Central Universities

Zitieren

APA

Peng, H., Yao, F., Zhao, J., Zhang, W., Chen, L., Wang, X., Yang, P., Tang, J., & Chi, Y. (2023). Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration, 3(2). https://doi.org/10.1002/exp.20220115

Vancouver

Peng H, Yao F, Zhao J, Zhang W, Chen L, Wang X, et al. Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials. Exploration. 2023;3(2). doi:10.1002/exp.20220115

BibTeX
@article{Peng2023,
  author = {Peng, Haibao and Yao, Feibai and Zhao, Jiaxu and Zhang, Wei and Chen, Lingchao and Wang, Xin and Yang, Peng and Tang, Jing and Chi, Yudan},
  title = {Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials},
  journal = {Exploration},
  year = {2023},
  volume = {3},
  number = {2},
  doi = {10.1002/exp.20220115}
}
Kostenlos starten →